抗癌平丸联合肝动脉栓塞化疗术治疗中晚期肝癌临床研究  

Clinical Efficacy of Kangaiping Pill Combined with Transcatheter Hepatic Arterial Chemoembolization Treating for Advanced Liver Cancer

作　　者：陈丽[1] 

机构地区：[1]保定市第五医院,河北保定071000

出　　处：《中医学报》2016年第1期23-25,共3页Acta Chinese Medicine

基　　金：中国高等教育专项基金(28745)

摘　　要：目的:观察抗癌平丸联合肝动脉栓塞化疗术治疗中晚期肝癌的临床疗效。方法:将64例患者随机分为对照组和治疗组,对照组32例采用肝动脉栓塞化疗术治疗,治疗组32例在对照组治疗基础上加用抗癌平丸治疗。治疗后比较两组患者的临床疗效、生活质量和近期生存率。结果:两组患者有效率、肿瘤控制率比较,差异无统计学意义(P>0.05);治疗组患者的生活质量改善率、中位生存期以及1 a、2 a的生存率均明显高于对照组,差异有统计学意义(P<0.05)。结论:采用抗癌平丸联合肝动脉栓塞化疗术治疗中晚期肝癌能改善患者生活质量、减缓疾病进展,是一种比较有效、安全的治疗方法。Objective： To observe the clinical efficacy of Kangaiping Pill combined with transcatheter hepatic arterial chemoembolization in treating for advanced liver cancer. Methods： 64 patients with advanced liver cancer were randomly divided into treatment group and control group,each with 32 cases. Transcatheter hepatic arterial chemoembolization method was applied to the control group,while Kangaiping Pill combined with transcatheter hepatic arterial chemoembolization was applied to the treatment group.The data of clinical efficacy,life quality and survival rate were compared of the two groups. Result： There were no significant differences in the efficacy and tumor growth control of the two groups（ P〉0. 05）,while the life quality improvement rate,the median survival time and 1a,2a survival rate of the treatment group is significantly higher than that of the control group（ P〈0. 05）. Conclusion： Kangaiping Pill combined with transcatheter hepatic arterial chemoembolization is an effective and safe treatment of advanced liver cancer,which can improve the life quality of patients and slow down the progress of the disease.

关 键 词：中晚期肝癌 抗癌平丸 肝动脉栓塞化疗术 

分 类 号：R273.357[医药卫生—中西医结合]